156 related articles for article (PubMed ID: 33108214)
1. Neurokinin-1 Receptor Inhibition and Cough.
Turner RD; Birring SS
Am J Respir Crit Care Med; 2021 Mar; 203(6):672-674. PubMed ID: 33108214
[No Abstract] [Full Text] [Related]
2. Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights.
Smith JA; Harle A; Dockry R; Holt K; Russell P; Molassiotis A; Yorke J; Robinson R; Birrell MA; Belvisi MG; Blackhall F
Am J Respir Crit Care Med; 2021 Mar; 203(6):737-745. PubMed ID: 32966755
[No Abstract] [Full Text] [Related]
3. Emerging targets for cough therapies; NK1 receptor antagonists.
Badri H; Smith JA
Pulm Pharmacol Ther; 2019 Dec; 59():101853. PubMed ID: 31622673
[TBL] [Abstract][Full Text] [Related]
4. Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.
Noronha V; Bhattacharjee A; Patil VM; Joshi A; Menon N; Shah S; Kannan S; Mukadam SA; Maske K; Ishi S; Prabhash K
Chest; 2020 Jun; 157(6):1647-1655. PubMed ID: 31958446
[TBL] [Abstract][Full Text] [Related]
5. Antitussive activity of the tachykinin NK1 receptor antagonist, CP-99994, in dogs.
Chapman RW; House A; Liu F; Celly C; Mei H; Hey JA
Eur J Pharmacol; 2004 Feb; 485(1-3):329-32. PubMed ID: 14757157
[TBL] [Abstract][Full Text] [Related]
6. Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?
Muñoz M; Muñoz ME; Morell F; Coveñas R
Arch Bronconeumol; 2022 Oct; 58(10):727-728. PubMed ID: 35606264
[No Abstract] [Full Text] [Related]
7. [Clinical considerations on a new antitussive agent].
Tansini G; Cavallaro G
Minerva Med; 1971 Feb; 62(17):828-32. PubMed ID: 5551770
[No Abstract] [Full Text] [Related]
8. Central mechanisms II: pharmacology of brainstem pathways.
Bolser DC
Handb Exp Pharmacol; 2009; (187):203-17. PubMed ID: 18825342
[TBL] [Abstract][Full Text] [Related]
9. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig.
Girard V; Naline E; Vilain P; Emonds-Alt X; Advenier C
Eur Respir J; 1995 Jul; 8(7):1110-4. PubMed ID: 7589394
[TBL] [Abstract][Full Text] [Related]
10. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1).
Smith J; Allman D; Badri H; Miller R; Morris J; Satia I; Wood A; K Trower M
Chest; 2020 Jan; 157(1):111-118. PubMed ID: 31421110
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-pharmacological considerations on antitussive preparations. Observations on a new synthetic product].
Fornaroli E; Zacco R
Minerva Med; 1970 May; 61(38):2072-9. PubMed ID: 5430926
[No Abstract] [Full Text] [Related]
12. Current and future prospects for drugs to suppress cough.
Chung KF
IDrugs; 2003 Aug; 6(8):781-6. PubMed ID: 12917774
[TBL] [Abstract][Full Text] [Related]
13. [Clinical trial of the antitussive action of an association of codeine plus phenyltoloxamine].
Dotti A
G Ital Mal Torace; 1970; 24(3):147-57. PubMed ID: 5492933
[No Abstract] [Full Text] [Related]
14. [Clinical research with promolate (morphethylbutyne) as antitussive agent in some respiratory diseases].
Visentin G; Di Vittorio G
Clin Ter; 1979 Jul; 90(2):173-9. PubMed ID: 393449
[No Abstract] [Full Text] [Related]
15. Delta-opioid receptor antagonists as a new concept for central acting antitussive drugs.
Kamei J
Pulm Pharmacol Ther; 2002; 15(3):235-40. PubMed ID: 12099770
[TBL] [Abstract][Full Text] [Related]
16. [Methods in cough experiments. Clinical testing of antitussive agents].
Seeber F
HNO; 1969 Sep; 17(9):270-3. PubMed ID: 5405514
[No Abstract] [Full Text] [Related]
17. Benzonatate for opioid-resistant cough in advanced cancer.
Doona M; Walsh D
Palliat Med; 1998 Jan; 12(1):55-8. PubMed ID: 9616460
[TBL] [Abstract][Full Text] [Related]
18. Drugs to suppress cough.
Chung KF
Expert Opin Investig Drugs; 2005 Jan; 14(1):19-27. PubMed ID: 15709918
[TBL] [Abstract][Full Text] [Related]
19. Antitussive effect of nociceptin/orphanin FQ in experimental cough models.
McLeod RL; Bolser DC; Jia Y; Parra LE; Mutter JC; Wang X; Tulshian DB; Egan RW; Hey JA
Pulm Pharmacol Ther; 2002; 15(3):213-6. PubMed ID: 12099766
[TBL] [Abstract][Full Text] [Related]
20. [Drug information. Antitussive agents must stop dry cough or loosen secretions].
Dahlerup J
Sygeplejersken; 1988 Oct; 88(43):16-7. PubMed ID: 3256079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
